title: Simultaneous measurement of collagen type-VI-related antigen and procollagen type-III-N-propeptide levels in bronchoalveolar lavage.
abstract: Abnormal collagen metabolism is a hallmark of diffuse lung disease. Biochemical parameters which are correlated with collagen synthesis and degradation may be helpful to monitor fibrosis. In this study, we compared the sensitivity and specificity of procollagen type-III-N-propeptide (PIIINP) and collagen type-VI (C-VI) related antigen levels, as well as a ratio of both parameters (PIIINP/C-VI), in bronchoalveolar lavage fluid (BALF) from patients with diffuse and localized lung disease. We investigated 45 patients with diffuse lung disease (idiopathic pulmonary fibrosis (IPF), n = 21; sarcoidosis, n = 13; and lymphangitic carcinomatosis (LC), n = 11); 58 control subjects; and 92 patients with localized lung disease (bronchial carcinoma, n = 37; pulmonary tuberculosis, n = 31; and pneumonia, n = 24). C-VI and PIIINP were measured by immunoassay in concentrated BALF. Although the PIIINP and C-VI levels were increased in diffuse lung disease, the sensitivity of the individual parameters PIIINP and C-VI was low (IPF: PIIINP = 0.62, C-VI = 0.29; LC: PIIINP = 0.64, C-VI = 0.45; sarcoidosis: PIIINP = 0.69, C-VI = 0.15). When calculating the ratio of PIIINP/C-VI for each individual patient, we found a significant increase in this ratio in IPF (1.28 +/- 0.7), LC (2.34 +/- 1.2), and sarcoidosis (0.26 +/- 0.08) compared to both the controls (0.02 +/- 0.01) and other localized lung diseases (bronchial carcinoma 0.05 +/- 0.01; pulmonary tuberculosis 0.02 +/- 0.01), with the exception of pneumonia (0.18 +/- 0.06).(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Dept of Pulmonary Medicine, Chest-Hospital Heckeshorn-Zehlendorf affiliated Freie Universität Berlin, Germany.
authors.forename: T
authors.initials: T
authors.lastname: Schaberg
authors.forename: K
authors.initials: K
authors.lastname: Orzechowski
authors.forename: C
authors.initials: C
authors.lastname: Oesterling
authors.forename: H
authors.initials: H
authors.lastname: Lode
authors.forename: D
authors.initials: D
authors.lastname: Schuppan
mesh_terms: D000328:Adult; D000941:Antigens / Q000032:analysis; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry*; D003094:Collagen / Q000032:analysis* / Q000276:immunology; D006801:Humans; D008171:Lung Diseases / Q000378:metabolism*; D008175:Lung Neoplasms / Q000378:metabolism; D008875:Middle Aged; D010446:Peptide Fragments / Q000032:analysis*; D018410:Pneumonia, Bacterial / Q000378:metabolism; D011347:Procollagen / Q000032:analysis*; D011658:Pulmonary Fibrosis / Q000378:metabolism; D017565:Sarcoidosis, Pulmonary / Q000378:metabolism; D012680:Sensitivity and Specificity; D014397:Tuberculosis, Pulmonary / Q000378:metabolism
chemical_list: D000941:Antigens; D010446:Peptide Fragments; D011347:Procollagen; C041876:procollagen Type III-N-terminal peptide; D003094:Collagen